• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Moonwalk Biosciences, Inc.

Monday, June 03, 2024
CP
Cell and Gene Therapy and Genome Editing
Moonwalk's novel platform technology provides a complete view of the epigenome in health and disease, with the most advanced AI prediction of epigenetic targets, and the broadest set of epigenetic engineering tools. The company was co-founded by Alex Aravanis, M.D., Ph.D., former CTO of Illumina, world-renowned scientist Feng Zhang, Ph.D. of the Broad Institute of MIT and Harvard, and a distinguished set of industry leaders and company builders. Moonwalk launched in January 2024 with $57 million raised led by Alpha Wave Ventures, and joined by other leading life sciences investors ARCH Venture Partners, Future Ventures, GV, Khosla Ventures and YK Bioventures.
Moonwalk Biosciences, Inc.
Company Website: https://moonwalk.bio/
Lead Product in Development: Not disclosed
Number Of Unlicensed Products (For Which You Are Seeking Partners): We seek partners for our unique epigenetic read & write platform technology.

Company HQ City

South San Francisco

Company HQ State

CA

Company HQ Country

United States

CEO/Top Company Official

Alex Aravanis

Development Phase of Primary Product

Discovery
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS